Eloise Kok
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Alzheimer's disease research and treatments 6
-
- Metabolomics and Mass Spectrometry Studies 3
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
- Co-authors
- Pekka J. Karhunen (11 shared papers)Teemu M. Luoto (5 shared papers)Sirkka Goebeler (4 shared papers)Hannu Haapasalo (4 shared papers)Heini Huhtala (1 shared paper)Hugo Lövheim (4 shared papers)Jan Olsson (4 shared papers)Fredrik Elgh (4 shared papers)
- Journals
- Addiction Biology (2 papers)Annals of Neurology (2 papers)Acta Neuropathologica Communications (1 paper)Alzheimer s Research & Therapy (1 paper)Disease Models & Mechanisms (1 paper)
- Partner nations
- FinlandSwedenUnited Kingdom
In The Last Decade
Eloise Kok
19 papers receiving 632 citations
Peers
Comparison fields: 5 of 98
- Biological Psychiatry 68
- Neurology 98
- Physiology 289
- Hepatology 66
- Psychiatry and Mental health 120
Countries citing papers authored by Eloise Kok
This map shows the geographic impact of Eloise Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eloise Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eloise Kok more than expected).
Fields of papers citing papers by Eloise Kok
This network shows the impact of papers produced by Eloise Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eloise Kok. The network helps show where Eloise Kok may publish in the future.
Co-authors
The 25 scholars most cited alongside Eloise Kok, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 228 | |
| 2 | 1999 | 78 | |
| 3 | 2022 | 76 | |
| 4 | 2017 | 47 | |
| 5 | 2019 | 45 | |
| 6 | 2016 | 35 | |
| 7 | 2011 | 25 | |
| 8 | 2016 | 21 | |
| 9 | 2008 | 18 | |
| 10 | 2012 | 17 | |
| 11 | 2011 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2024 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2019 | 7 | |
| 16 | 2022 | 7 | |
| 17 | 2012 | 5 | |
| 18 | 2024 | 2 | |
| 19 | 2025 | 2 | |
| 20 | 2025 | 0 |
About Eloise Kok
Eloise Kok is a scholar working on Physiology, Molecular Biology, Neurology, Epidemiology and Surgery, having authored 20 papers that have together received 650 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Parkinson's Disease Mechanisms and Treatments (5 papers), Metabolomics and Mass Spectrometry Studies (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Herpesvirus Infections and Treatments (3 papers), Tryptophan and brain disorders (2 papers), Neurological disorders and treatments (2 papers) and Dementia and Cognitive Impairment Research (2 papers). The work is most often cited by research in Biological Psychiatry (68 citations), Neurology (98 citations), Physiology (289 citations), Hepatology (66 citations) and Psychiatry and Mental health (120 citations). Eloise Kok has collaborated with scholars based in Finland, Sweden and United Kingdom. Frequent co-authors include Pekka J. Karhunen, Teemu M. Luoto, Sirkka Goebeler, Hannu Haapasalo, Heini Huhtala, Hugo Lövheim, Jan Olsson, Fredrik Elgh, Rolf Adolfsson and Anna Raunio. Their work appears in journals such as Addiction Biology, Annals of Neurology, Acta Neuropathologica Communications, Alzheimer s Research & Therapy and Disease Models & Mechanisms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.